|
|
Volumn 43, Issue 12, 2016, Pages 2094-2100
|
|
Safety and efficacy of SBI-087, a subcutaneous agent for B cell depletion, in patients with active rheumatoid arthritis: Results from a phase II randomized, double-blind, placebo-controlled study
a
|
|
Author keywords
B cell depletion; Drug safety; Pharmacodynamics; RHeumatoid arthritis; SBI 087 efficacy
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
CORTICOSTEROID;
CYCLIC CITRULLINATED PEPTIDE ANTIBODY;
METHOTREXATE;
PLACEBO;
RHEUMATOID FACTOR;
SBI 087;
UNCLASSIFIED DRUG;
ANTIRHEUMATIC AGENT;
PROTEIN;
SBI-087;
ADULT;
ANALYSIS OF COVARIANCE;
ARTICLE;
B LYMPHOCYTE;
BRONCHITIS;
CONTROLLED STUDY;
DAS28;
DIARRHEA;
DISEASE CLASSIFICATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
FUNCTIONAL STATUS ASSESSMENT;
GLOBAL ASSESSMENT OF FUNCTIONING;
HEADACHE;
HEALTH ASSESSMENT QUESTIONNAIRE;
HUMAN;
HYPERTENSION;
INFLUENZA;
LEUKOPENIA;
LYMPHOCYTE DEPLETION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OUTCOME ASSESSMENT;
PHARMACODYNAMICS;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
RHINOPHARYNGITIS;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
VISUAL ANALOG SCALE;
AGED;
CLINICAL TRIAL;
COMBINATION DRUG THERAPY;
DRUG EFFECT;
MIDDLE AGED;
PROCEDURES;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
B-LYMPHOCYTES;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
LYMPHOCYTE DEPLETION;
MALE;
METHOTREXATE;
MIDDLE AGED;
PROTEINS;
TREATMENT OUTCOME;
|
|
EID: 85002525422
PISSN: 0315162X
EISSN: 14992752
Source Type: Journal
DOI: 10.3899/jrheum.160146 Document Type: Article |
|
Times cited : (5)
|
|
References (11)
|
